All Dr Christopher Haqq (Elicio) articles

  • DTR - Beyond the Lab - Vaccine development 2024_750x500
    Report

    Beyond the lab: vaccine development

    2024-03-22T08:30:04Z

    This report provides insights into current research and future prospects from potential breakthroughs to global collaboration in pandemic preparedness.

  • Chris Haqq Headshot
    Article

    The future of cancer immunotherapy with Elicio Therapeutics

    2024-03-01T09:03:37Z

    In this exclusive interview with Dr Christopher Haqq, Executive Vice President, Head of Research and Development, and Chief Medical Officer of Elicio Therapeutics, we explore the latest in Cancer Immunology Research. The study highlights the promising preclinical data demonstrating the potential of TCR-T cell therapy in combination with lymph node-targeted ...